Capital Fund Management (CFM)’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$14.5M Sell
41,200
-55,900
-58% -$19.9M 0.07% 417
2025
Q4
$31.8M Sell
97,100
-120,000
-55% -$38.1M 0.09% 311
2025
Q3
$61.3M Buy
217,100
+25,100
+13% +$7.28M 0.16% 140
2025
Q2
$53.6M Sell
192,000
-39,900
-17% -$11.3M 0.15% 194
2025
Q1
$72.2M Buy
231,900
+136,600
+143% +$40.3M 0.21% 131
2024
Q4
$24.8M Sell
95,300
-78,800
-45% -$23.4M 0.06% 408
2024
Q3
$56.1M Sell
174,100
-95,200
-35% -$31.1M 0.15% 173
2024
Q2
$84.1M Sell
269,300
-40,100
-13% -$11.8M 0.25% 102
2024
Q1
$88M Buy
309,400
+119,200
+63% +$34.9M 0.25% 88
2023
Q4
$54.8M Sell
190,200
-70,200
-27% -$19.1M 0.15% 178
2023
Q3
$70M Sell
260,400
-125,600
-33% -$31.3M 0.24% 95
2023
Q2
$85.7M Buy
386,000
+187,900
+95% +$43.6M 0.35% 53
2023
Q1
$47.9M Buy
198,100
+181,500
+1,093% +$44.6M 0.23% 109
2022
Q4
$4.36M Sell
16,600
-10,300
-38% -$2.76M 0.03% 658
2022
Q3
$6.06M Sell
26,900
-3,100
-10% -$751K 0.05% 483
2022
Q2
$7.3M Buy
+30,000
New +$7.35M 0.07% 407
2021
Q4
Sell
-20,700
Closed -$4.4M 1570
2021
Q3
$4.4M Hold
20,700
0.03% 628
2021
Q2
$5.05M Buy
+20,700
New +$5.09M 0.04% 559
2021
Q1
Sell
-17,200
Closed -$3.95M 1249
2020
Q4
$3.95M Sell
17,200
-10,900
-39% -$2.51M 0.04% 550
2020
Q3
$7.14M Sell
28,100
-48,600
-63% -$12M 0.09% 264
2020
Q2
$18.1M Sell
76,700
-99,100
-56% -$22.6M 0.29% 98
2020
Q1
$35.6M Buy
175,800
+75,100
+75% +$16.4M 0.55% 26
2019
Q4
$24.3M Buy
100,700
+97,900
+3,496% +$21.6M 0.19% 132
2019
Q3
$542K Buy
+2,800
New +$537K ﹤0.01% 1225
2018
Q4
Sell
-41,800
Closed -$8.66M 1816
2018
Q3
$8.66M Buy
41,800
+32,900
+370% +$6.48M 0.05% 540
2018
Q2
$1.64M Sell
8,900
-6,000
-40% -$1.06M 0.01% 1159
2018
Q1
$2.54M Buy
14,900
+1,300
+10% +$239K 0.02% 924
2017
Q4
$2.37M Sell
13,600
-21,400
-61% -$3.79M 0.01% 933
2017
Q3
$6.53M Buy
35,000
+33,600
+2,400% +$5.95M 0.05% 459
2017
Q2
$241K Sell
1,400
-17,500
-93% -$2.85M ﹤0.01% 1340
2017
Q1
$3.1M Buy
18,900
+13,200
+232% +$2.19M 0.03% 614
2016
Q4
$833K Sell
5,700
-105,400
-95% -$15.9M 0.01% 1084
2016
Q3
$18.5M Buy
111,100
+105,900
+2,037% +$17.9M 0.17% 162
2016
Q2
$791K Sell
5,200
-53,200
-91% -$8.27M 0.01% 1027
2016
Q1
$8.76M Buy
58,400
+36,600
+168% +$5.44M 0.09% 278
2015
Q4
$3.54M Sell
21,800
-4,700
-18% -$739K 0.04% 529
2015
Q3
$3.67M Sell
26,500
-57,000
-68% -$8.98M 0.04% 464
2015
Q2
$12.8M Sell
83,500
-261,400
-76% -$41.9M 0.16% 175
2015
Q1
$55.1M Buy
344,900
+70,300
+26% +$11.1M 0.75% 11
2014
Q4
$43.7M Buy
274,600
+137,400
+100% +$21.4M 0.52% 24
2014
Q3
$19.3M Buy
137,200
+51,500
+60% +$6.72M 0.22% 102
2014
Q2
$10.1M Sell
85,700
-24,700
-22% -$2.86M 0.11% 230
2014
Q1
$13.6M Sell
110,400
-58,600
-35% -$7.11M 0.17% 134
2013
Q4
$19.3M Sell
169,000
-67,700
-29% -$7.7M 0.24% 69
2013
Q3
$26.5M Buy
236,700
+158,400
+202% +$17.2M 0.37% 47
2013
Q2
$7.72M Buy
+78,300
New +$8.13M 0.12% 216

Other funds holding AMGN

Capital Fund Management (CFM)'s AMGN Position: Q1 2026 in Review

Capital Fund Management (CFM) reduced its Amgen (AMGN) stake by 75% in Q1 2026, selling an estimated $13.6M and leaving 12,941 shares worth $4.55M. The position accounts for 0.02% of the portfolio, ranked #937.

Capital Fund Management (CFM) first reported a position in AMGN in Q2 2013 and has held it in 37 quarters since. The position peaked at $87.3M in Q2 2019. 3,127 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Capital Fund Management (CFM) held 12,941 shares of Amgen worth $4.55M as of Q1 2026.
  • Capital Fund Management (CFM) sold 38,187 Amgen shares in Q1 2026, an estimated $13.6M.
  • Amgen made up 0.02% of Capital Fund Management (CFM)'s portfolio in Q1 2026, its #937 holding.
  • Capital Fund Management (CFM) first reported a position in Amgen in Q2 2013 and has held it in 37 quarters since.
  • Capital Fund Management (CFM)'s Amgen position peaked at $87.3M in Q2 2019.
  • 3,127 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Capital Fund Management (CFM)'s 13F filing for Q1 2026, filed 14 May 2026.